Stock Price Quote

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE1605.00-3.1 (-0.19 %)
PREV CLOSE ( ) 1608.10
OPEN PRICE ( ) 1611.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3439
TODAY'S LOW / HIGH ( )1601.00 1629.00
52 WK LOW / HIGH ( )1379 1805
NSE1603.95-3.8 (-0.24 %)
PREV CLOSE( ) 1607.75
OPEN PRICE ( ) 1615.80
BID PRICE (QTY) 1603.95 (91)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 35030
TODAY'S LOW / HIGH( ) 1599.55 1635.95
52 WK LOW / HIGH ( )1376 1807.5
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-11 1924
Management Info
R S Karnad - Chairman S Venkatesh - Managing Director
Registered Office

Address Dr Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email askus@gsk.com

Website www.gsk-india.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

27Jul GlaxoSmithKline Pharmaceuticals to tra
GlaxoSmithKline Pharmaceuticals has decided to transfer its rights in re..
27Jul Vodafone Idea, Biocon and Bajaj Auto t
Vodafone Idea’s (VIL) enterprise arm -- Vodafone Idea (VIL), Vi Business..
06Jul Board Meeting Intimation for Un- Audi
GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of..
01Jun GlaxoSmithKline Pharmaceuticals inform
GlaxoSmithKline Pharmaceuticals has informed that the company will hold..
19May Glaxosmithkline Pharmaceuticals inform
In compliance with the provisions of Regulation 24A of SEBI LODR Amendme..

Financials

in Millions
QTR Jun 21 ANNUAL 21
Net Profit12043575.6
Gross Profit 1639.2 5497.3
Operating Profit 1824.28051.4
Net Sales 7734.631937.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  19748.15 (3.47%)
M.Cap ( in Cr)41963.44
Sanofi India (BSE)
peergroup  8545.05 (2.12%)
M.Cap ( in Cr)19679.78
Piramal Enterprises (BSE)
peergroup  2489.35 (7.40%)
M.Cap ( in Cr)56526.72
NGL Fine-Chem (BSE)
peergroup  3437.15 (5.00%)
M.Cap ( in Cr)2123.48
Solara Active Pharma (BSE)
peergroup  1732.65 (5.36%)
M.Cap ( in Cr)6225.37

Shareholding Pattern

PROMOTERS 75%
MUTUAL FUNDS/UTI 4.07%
NON-INSTITUTION 12.46%
FI/BANKS/INSURANCE 1.44%
FII 0%
GOVERNMENT 0%

About Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd. was incorporated in the year 1924. Its today's share price is 1605. Its current market capitalisation stands at Rs 27189.67 Cr. In the latest quarter, company has reported Gross Sales of Rs. 31937.36 Cr and Total Income of Rs.33039.24 Cr. The company's management includes Mark Dawson, Ajay Nadkarni, S Williams, P Thakur, D Sundaram, A N Roy, S Maheshwari, N Kaviratne ( C B E ), PV Bhide, S Venkatesh, R S Karnad.

It is listed on the BSE with a BSE Code of 500660 , NSE with an NSE Symbol of GLAXO and ISIN of INE159A01016. It's Registered office is at Dr Annie Besant Road,Worli,Mumbai-400030, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, Lovelock & Lewes, Price Waterhouse & Co, Price Waterhouse & Co Bangalore LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)